JP2008536825A5 - - Google Patents

Download PDF

Info

Publication number
JP2008536825A5
JP2008536825A5 JP2008504368A JP2008504368A JP2008536825A5 JP 2008536825 A5 JP2008536825 A5 JP 2008536825A5 JP 2008504368 A JP2008504368 A JP 2008504368A JP 2008504368 A JP2008504368 A JP 2008504368A JP 2008536825 A5 JP2008536825 A5 JP 2008536825A5
Authority
JP
Japan
Prior art keywords
phenyl
alkyl
piperidin
ethyl
ethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008504368A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008536825A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/011663 external-priority patent/WO2006105304A2/en
Publication of JP2008536825A publication Critical patent/JP2008536825A/ja
Publication of JP2008536825A5 publication Critical patent/JP2008536825A5/ja
Withdrawn legal-status Critical Current

Links

JP2008504368A 2005-03-31 2006-03-30 フェニルおよびピリジルlta4hモジュレータ Withdrawn JP2008536825A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66719905P 2005-03-31 2005-03-31
PCT/US2006/011663 WO2006105304A2 (en) 2005-03-31 2006-03-30 Phenyl and pyridyl lta4h modulators

Publications (2)

Publication Number Publication Date
JP2008536825A JP2008536825A (ja) 2008-09-11
JP2008536825A5 true JP2008536825A5 (enExample) 2009-05-14

Family

ID=36950133

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008504368A Withdrawn JP2008536825A (ja) 2005-03-31 2006-03-30 フェニルおよびピリジルlta4hモジュレータ

Country Status (17)

Country Link
US (1) US20060223792A1 (enExample)
EP (1) EP1868605A2 (enExample)
JP (1) JP2008536825A (enExample)
KR (1) KR20080003385A (enExample)
CN (1) CN101189012A (enExample)
AU (1) AU2006230379A1 (enExample)
BR (1) BRPI0607742A2 (enExample)
CA (1) CA2603122A1 (enExample)
CO (1) CO6382173A2 (enExample)
CR (1) CR9480A (enExample)
EA (1) EA200702128A1 (enExample)
IL (1) IL186432A0 (enExample)
MX (1) MX2007012235A (enExample)
NI (1) NI200700250A (enExample)
NO (1) NO20075429L (enExample)
WO (1) WO2006105304A2 (enExample)
ZA (1) ZA200709346B (enExample)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1976828T3 (pl) 2005-12-29 2017-07-31 Celtaxsys, Inc. Pochodne diaminy jako inhibitory hydrolazy leukotrienu a4
JP2009269819A (ja) * 2006-08-25 2009-11-19 Asahi Kasei Pharma Kk アミン化合物
EP2336125B1 (en) * 2008-04-11 2013-01-09 Janssen Pharmaceutica N.V. Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolase
US8399465B2 (en) * 2009-05-14 2013-03-19 Janssen Pharmaceutica Nv Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene A4 hydrolase
MX355309B (es) 2011-03-14 2018-04-16 Boehringer Ingelheim Int Inhibidores de benzodioxano de la produccion de leucotrieno.
WO2013012844A1 (en) 2011-07-19 2013-01-24 Boehringer Ingelheim International Gmbh Arylpyrazole ethers as inhibitors of leukotriene a4 hydrolase
FR2984730A1 (fr) * 2011-12-22 2013-06-28 Diverchim Nouvelles compositions cosmetiques anti-age et depigmentantes
AR091315A1 (es) 2012-03-06 2015-01-28 Boehringer Ingelheim Int Inhibidores de benzodioxano de la produccion de leucotrieno
JP6080226B2 (ja) 2012-03-06 2017-02-15 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 他の活性物質と組み合わせたロイコトリエン産生阻害用ベンゾジオキサン
US9403830B2 (en) 2012-07-17 2016-08-02 Boehringer Ingelheim International Gmbh Inhibitors of leukotriene production
JP6527851B2 (ja) 2013-03-12 2019-06-05 セルタクシス,インコーポレイテッド ロイコトリエンa4加水分解酵素を阻害する方法
AU2014239585B2 (en) * 2013-03-14 2019-04-04 Celtaxsys, Inc. Inhibitors of leukotriene A4 hydrolase
EP2968264A4 (en) 2013-03-14 2016-11-02 Celtaxsys Inc INHIBITORS OF LEUCOTRIENE A4 HYDROLASE
AU2014239567B2 (en) 2013-03-14 2017-12-14 Celtaxsys, Inc. Inhibitors of leukotriene A4 hydrolase
EP3022194B1 (en) 2013-07-15 2017-05-17 Boehringer Ingelheim International GmbH Inhibitors of leukotriene production
WO2015009609A1 (en) 2013-07-15 2015-01-22 Boehringer Ingelheim International Gmbh Inhibitors of leukotriene production
BR102013020313B1 (pt) * 2013-08-09 2021-07-06 Fundação Oswaldo Cruz derivados bifeniloxi-alquil-aminas e ariloxi-alquil-aminas, e, composição farmacêutica
WO2015091415A1 (de) 2013-12-19 2015-06-25 Bayer Pharma Aktiengesellschaft Substituierte bipiperidinyl-derivate als adrenorezeptor alpha 2c antagonisten
WO2015091414A2 (de) 2013-12-19 2015-06-25 Bayer Pharma Aktiengesellschaft Substituierte piperidinyl-tetrahydrochinoline
JP2017501164A (ja) 2013-12-19 2017-01-12 バイエル ファーマ アクチエンゲゼルシャフト 置換されたピペリジニルテトラヒドロキノリン類
WO2015091420A1 (de) * 2013-12-19 2015-06-25 Bayer Pharma Aktiengesellschaft Substituierte bipiperidinyl-derivate als adrenrezeptor alpha 2c antagonisten
KR101499007B1 (ko) * 2014-04-24 2015-03-05 고려대학교 산학협력단 염증성 질환의 예방 또는 치료용 약학 조성물
WO2016071792A1 (en) * 2014-11-03 2016-05-12 Laboratorio Chimico Internazionale S.P.A. Method for the preparation of 1-(2-halogen-ethyl)-4 piperidine-carboxylic acid ethyl esters
PT109740B (pt) 2016-11-14 2020-07-30 Hovione Farmaciencia Sa Processo para a preparação de brometo de umeclidínio
CN119528804A (zh) 2017-05-04 2025-02-28 发现号收购集团 作为例如用于保护植物的害虫防治剂的2-{[2-(苯氧基甲基)吡啶-5-基]氧基}乙胺衍生物及相关化合物
CA3102077A1 (en) 2018-05-31 2019-12-05 Sanjeev AHUJA Method of reducing pulmonary exacerbations in respiratory disease patients
CA3105542A1 (en) * 2018-07-31 2020-02-06 Novartis Ag Crystalline forms of a lta4h inhibitor
SG11202107080VA (en) * 2019-01-11 2021-07-29 Naegis Pharmaceuticals Inc Leukotriene synthesis inhibitors
CN110229091B (zh) * 2019-06-21 2022-11-22 天津科技大学 具有白三烯a4水解酶抑制作用的1,5-二取代吲哚衍生物及应用
CN113683491A (zh) * 2021-09-01 2021-11-23 王传良 一种4-(2-溴乙基)苯酚的制备方法
AU2022376563A1 (en) 2021-11-01 2023-12-07 Alkahest, Inc. Benzodioxane modulators of leukotriene a4 hydrolase (lta4h) for prevention and treatment of aging-associated diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4038412A (en) * 1975-08-25 1977-07-26 Richardson-Merrell Inc. N-(phenylether-substituted benzyl)alkanediamines
JPH0696532B2 (ja) * 1988-08-11 1994-11-30 山之内製薬株式会社 血小板活性化因子拮抗剤
EP0641766B1 (en) * 1991-10-04 1998-11-11 Taisho Pharmaceutical Co. Ltd Alkoxyphenylalkylamine derivative
US5585492A (en) * 1994-10-11 1996-12-17 G. D. Searle & Co. LTA4 Hydrolase inhibitors
US6506876B1 (en) * 1994-10-11 2003-01-14 G.D. Searle & Co. LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use
US5925654A (en) * 1997-03-12 1999-07-20 G.D. Searle & Co. LTA4 , hydrolase inhibitors
US6110944A (en) * 1997-03-12 2000-08-29 G. D. Searle & Co. LTA4, hydrolase inhibitors
WO2002044130A1 (fr) * 2000-11-29 2002-06-06 Kyorin Pharmaceutical Co., Ltd. Dérivés d'acide carboxylique substitués
UA87986C2 (uk) * 2003-07-28 2009-09-10 Янссен Фармацевтика Н.В. Бензімідазольні, бензтіазольні та бензоксазольні похідні і їх застосування як lta4h модуляторів
US7825109B2 (en) * 2003-08-29 2010-11-02 Ono Pharmaceutical Co., Ltd. Compound capable of binding S1P receptor and pharmaceutical use thereof

Similar Documents

Publication Publication Date Title
JP2008536825A5 (enExample)
TWI359140B (enExample)
AU2003213361B2 (en) Nitrogenous heterocyclic compound and medicine thereof
JP2007500703A5 (enExample)
EP2314586B1 (en) 2-Acylaminothiazole derivative or salt thereof
JP2006500348A5 (enExample)
JP2012508274A5 (enExample)
JP2006509715A5 (enExample)
JP2011512412A5 (enExample)
JPWO2020038415A5 (enExample)
JP2018519323A5 (enExample)
CA2796967A1 (en) Heterocyclic derivatives as alk inhibitors
NZ601794A (en) Di - substituted pyridine derivatives as anticancers
JP2017525757A5 (enExample)
JP2010514788A5 (enExample)
JP2010520893A5 (enExample)
CA2517888A1 (en) Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
JP2018515555A5 (enExample)
JP2006506380A5 (enExample)
CA2585053A1 (en) Substituted n-acyl (hetero)aryl compounds as c-fms kinase inhibitors
JP2012530765A5 (enExample)
RU2006100190A (ru) Производные хинолиламида в качестве антагонистов ccr-5
JP2010526801A5 (enExample)
JP2010536821A5 (enExample)
JP2008517042A5 (enExample)